Gestational diabetes mellitus (GDM) is a common medical complication of pregnancy, affecting up to 14% of pregnancies worldwide. The condition is associated with numerous short-term and long-term maternal and fetal complications. Hence, healthcare professionals need to be equipped with the knowledge and skills to effectively manage GDM to optimize outcomes for both mother and baby.
Early detection of GDM is crucial for effective management. Universal screening, using either the one-step or two-step approach, is recommended between 24 and 28 weeks of gestation. However, high-risk women should be screened at the first prenatal visit. Diagnosis is based on elevated plasma glucose levels during an oral glucose tolerance test.
Management of GDM primarily involves lifestyle modifications, including a balanced diet and regular physical activity. Medical nutrition therapy is the cornerstone of treatment, aiming to provide adequate nutrition while maintaining euglycemia. If lifestyle modifications are insufficient, insulin therapy may be required. Oral hypoglycemic agents, such as metformin or glyburide, are alternatives when insulin is contraindicated or unacceptable to the patient.
Regular monitoring of maternal glycemic control and fetal growth is vital. Self-monitoring of blood glucose and regular antenatal visits are recommended. Postpartum follow-up is essential to screen for type 2 diabetes and provide lifestyle counseling to reduce long-term risk.
Effective management of GDM requires an interdisciplinary approach, involving obstetricians, endocrinologists, dietitians, and diabetes educators. A team-based approach ensures comprehensive care and enhances patient adherence to management plans.
Optimizing outcomes in GDM requires timely diagnosis, effective management strategies, regular monitoring, and an interdisciplinary approach. By staying abreast of the latest evidence-based practices, healthcare professionals can significantly improve the health outcomes of women with GDM and their offspring.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation